Heart Rate Control in Atrial Fibrillation During Acute Myocardial Infarction

Introduction to Rate Control

The American College of Cardiology recommends intravenous beta-blockers, specifically metoprolol or atenolol, as the preferred first-line agents for rate control in atrial fibrillation during acute myocardial infarction, provided the patient does not have severe heart failure, pulmonary disease, or hemodynamic instability 1

Beta-blockers are recommended by ACC/AHA guidelines as the most effective means of slowing ventricular rate in AF during acute MI, due to their dual benefit of controlling heart rate and reducing myocardial oxygen demand 1
The American College of Cardiology guidelines suggest that beta-blockers have a proven mortality benefit in acute MI patients, making them superior to other rate-control agents in this specific context 1

For IV metoprolol, the American College of Cardiology recommends administering 2.5-5 mg IV every 2-5 minutes to a total of 15 mg over 10-15 minutes, with continuous monitoring of heart rate, blood pressure, and ECG 1
For IV atenolol, the American College of Cardiology recommends administering 2.5-5 mg IV over 2 minutes, up to 10 mg total over 10-15 minutes 1

If beta-blockers are contraindicated due to severe heart failure with reduced ejection fraction, the American College of Cardiology recommends using IV amiodarone, with a dose of 150 mg over 10 minutes, followed by 1 mg/min infusion for 6 hours, then 0.5 mg/min maintenance 1, 2, 3
If beta-blockers are contraindicated due to severe bronchospasm/COPD, the American College of Cardiology suggests considering IV diltiazem or verapamil, though these are second-line in the MI setting 2

The American College of Cardiology advises against using non-dihydropyridine calcium channel blockers (diltiazem/verapamil) as first-line in acute MI, due to the preference for beta-blockers in this context 1, 2
The American College of Cardiology recommends avoiding digoxin as monotherapy in acute settings, as it is less effective for acute rate control and works primarily at rest, not during the sympathetic surge of acute MI 2, 3

Atrial fibrillation occurs more frequently with anterior MIs and larger infarcts, according to the American College of Cardiology 1
Thrombolytic therapy reduces AF incidence, so early reperfusion is protective, as stated by the American College of Cardiology 1
The American College of Cardiology recommends correcting electrolyte abnormalities, such as hypokalemia and hypomagnesemia, which commonly precipitate AF in acute MI 1

The American College of Cardiology suggests assessing hemodynamic stability first, and if unstable, proceeding directly to electrical cardioversion 1
If hemodynamically stable, the American College of Cardiology recommends assessing cardiac function, and using IV metoprolol or atenolol as first-line for preserved LV function, and IV amiodarone for reduced LV function/decompensated HF 1, 2, 3